Updates, Research
& Publications
The latest from Avesta — news milestones, peer-reviewed publications, and scientific white papers from our research programs.
Avesta Bio Invited to Present at Dubai World Health Expo 2026 (WHX Dubai)
Burjeel Cancer Institute, Avesta Bio partner to advance cancer research, innovation
Avesta Bio Selected to Present at the 27th Annual SoCalBio Investor & Partnering Conference
Avesta Bio Hosts Exclusive Community Event at Loews Hotel in Arlington, Texas
Avesta Bio Invited to Present at IPI Campden Denver
All News
11 Articles Avesta Bio Invited to Present at Dubai World Health Expo 2026 (WHX Dubai)
Burjeel Cancer Institute, Avesta Bio partner to advance cancer research, innovation
Avesta Bio Selected to Present at the 27th Annual SoCalBio Investor & Partnering Conference
Avesta Bio Hosts Exclusive Community Event at Loews Hotel in Arlington, Texas
Avesta Bio Invited to Present at IPI Campden Denver
Avesta Bio Wins First Place at 2025 BioScienceLA Startup Pitch Competition
Avesta Bio CEO Ian Akash Morrison Named to BioScienceLA Week Hosting Committee
Avesta Bio Selected to Present at the 2024 Texas Life Science Forum
Texas Tech University Honors Avesta Bio with 2023 Research Commercialization Deal of the Year Award
Avesta Bio Selected to Present at The Lundquist Institute’s 2023 Innovation Annual Showcase
Attomarker and Avesta Bio Announce Strategic Partnership to Advance Precision Oncology
Selected Publications
Peer-reviewed research underpinning the science of RLIP76Rlip depletion prevents spontaneous neoplasia in TP53 null mice
Shows that depleting RLIP76 prevents spontaneous tumor formation in mice lacking p53 and extends their survival.
A Central Role of RLIP76 in Regulation of Glycemic Control
Establishes RLIP76 as a central regulator of blood glucose, insulin sensitivity, and lipid levels.
Enhancing carboplatin sensitivity in ovarian cancer cells by blocking the mercapturic acid pathway transporter
Shows that blocking RLIP76 increases the sensitivity of ovarian cancer cells to carboplatin.
RLIP depletion suppresses ovarian cancer growth and metastasis
Demonstrates that RLIP76 depletion suppresses both tumor growth and metastasis in ovarian cancer models.
Rlip Depletion Suppresses Growth of Breast Cancer
Demonstrates that RLIP76 depletion suppresses breast tumor growth in preclinical models.
RLIP76: A Structural and Functional Triumvirate
Reviews the structure, transport activity, and signaling functions of RLIP76, and its elevated levels across multiple cancers.
White Papers
RLIP76, a Key Regulator of p53 Signaling Pathways
Explores how RLIP76 links p53 signaling, oxidative stress, and cancer cell survival—and why its inhibition may have broad therapeutic potential across tumor types.
Treating Chronic Disease by Targeting RLIP76
Presents the connections between RLIP76 and the diseases associated with aging, and the platform extensions those connections support.
RLIP76: External Research Landscape, Historical Context, and Evolution of the Field
Details how institutions and scholars have engaged with Dr. Sanjay Awasthi’s RLIP76 research over time.